Children under five years of age, especially those aged two years or under, face a high risk of pneumococcal disease, which is caused by infection of a bacteria -- Streptococcus pneumoniae ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...

Vaccination and HIV treatment reduce the risk of invasive pneumococcal disease. Pneumococcal disease is treated with antibiotics. Pneumococcal disease is caused by a bacterium called Streptococcus ...

Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, and may help prevent infections including ear infections, pneumonia (lung infection ...

With Capvaxive, MSD (known as Merck & Co in the US and Canada) is aiming to carve out a niche in the over-50s, positioning it as the go-to vaccine used to prevent invasive pneumococcal disease ...

Spring is on the horizon and the days are getting a little bit longer. Seeing extra sun and warmth after winter’s chill ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

"Given the vast unmet public health needs in invasive pneumococcal disease (IPD), we’re delighted to expand this collaboration and continue our pursuit of innovative work in PCV," remarked ...

A recent analysis of Black and non-Black US adults with pneumococcal disease aged 50 years and older found racial disparity costs as high as $1157 million, opening the door to discussions for ...

“Invasive pneumococcal disease and pneumococcal pneumonia remain critical public health challenges worldwide,” said Dr. Paula Annunziato, senior vice president, infectious diseases and ...

However, increase in disease-causing or colonizing pneumococcal strains with intermediate resistance due to selective pressure can become a clinical concern. Therefore, changing trends should be ...